Gilead Sciences, Inc’s recent filing unveils that its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $14.07 million on Feb 12 ’25. In the deal valued at $102.22 per share,137,676 shares were sold. As a result of this transaction, Dickinson Andrew D now holds 171,223 shares worth roughly $ 17.82 million.
Then, ANDREW DICKINSON bought 137,676 shares, generating $14,073,241 in total proceeds.
Before that, Dickinson Andrew D sold 142,180 shares. Gilead Sciences, Inc shares valued at $13,822,740 were divested by the Chief Financial Officer at a price of $97.22 per share. As a result of the transaction, Dickinson Andrew D now holds 129,873 shares, worth roughly $13.52 million.
DZ Bank upgraded its Gilead Sciences, Inc [GILD] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in early January from “an Equal-weight” to “an Overweight”. Wolfe Research started covering the stock on November 15, 2024. It rated GILD as “an Outperform”.
Price Performance Review of GILD
On Friday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock fall -1.77% to $104.08. Over the last five days, the stock has gained 8.37%. Gilead Sciences, Inc shares have risen nearly 12.68% since the year began. Nevertheless, the stocks have risen 41.55% over the past one year. While a 52-week high of $106.43 was reached on 02/14/25, a 52-week low of $62.07 was recorded on 01/10/25. SMA at 50 days reached $93.91, while 200 days put it at $81.33.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 103.11, which if violated will result in even more drops to 102.13. On the upside, there is a resistance level at 105.87. A further resistance level may holdings at 107.66. The Relative Strength Index (RSI) on the 14-day chart is 68.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.97, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 20.26%. Stochastics %K at 88.33% indicates the stock is a selling.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2025-01-31, dropping by -2.73 million shares to a total of 22.93 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 25.66 million shares. There was a decline of -11.89%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 14, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $125 price target.
